Scientists hunt for clues to chemo resistance in blood cancer
NCT ID NCT07385612
First seen Feb 04, 2026 · Last updated Jun 19, 2026 · Updated 20 times
Summary
This study collects blood and bone marrow samples from 80 people with B-cell non-Hodgkin lymphoma to explore why some cancers resist chemotherapy. Researchers will analyze the tumor and its environment, and develop lab models to test new treatments. The goal is to uncover resistance mechanisms and identify genes involved, which could lead to better therapies in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH de Saint-Nazaire
Saint-Nazaire, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHD Vendée
La Roche-sur-Yon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Nantes
Nantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Poitiers
Poitiers, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could identify why some B-cell lymphomas resist chemotherapy, pointing toward new treatment targets.
What could go wrong
This is an observational study that collects samples, not a treatment trial. It may not directly lead to new therapies, and results may take years to translate into clinical use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.